NanoXplore (GRA) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
25 Mar, 2026Financial highlights and performance
Market capitalization stands at $445 million with $30.1 million in cash and $40.1 million in total liquidity as of February 2026.
Trailing twelve months (TTM) revenue reached $113.2 million, with Q2 2026 revenues at $27.6 million, rebounding from Q1.
Adjusted EBITDA for Q2 2026 was $0.181 million, with gross margin expanding to 23% due to higher revenues and operational leverage.
Long-term debt is $13.9 million, and the company employs approximately 375 people.
Strategic growth and expansion
Completed U.S. expansion with new production at the Statesville plant, contributing to revenue growth.
Signed a multi-year supply agreement with Chevron Phillips Chemical for proprietary carbon product Tribograf™.
Capacity expansion plan targets 1,000 tpa by April 2026, with modular dry-process graphene production and further growth aligned with demand.
$40M+ in incremental booked graphene-enhanced composite business starting in Q2 FY2026, with available capacity for further expansion.
Product and technology leadership
Offers a broad portfolio: graphene powders (wet and dry process), masterbatches, recycled plastic compounds, composite SMC, and advanced battery cells.
Dry-process graphene offers 40% lower production costs and enables carbon black replacement in plastics, foams, and energy storage.
Graphene products deliver high thermal and electrical conductivity, strength, and sustainability, with a significantly lower carbon footprint than carbon black.
Latest events from NanoXplore
- Sequential margin and revenue gains, strong liquidity, and new contracts drive future growth.GRA
Q2 202611 Feb 2026 - Record sales and margin gains achieved; VoltaXplore gigafactory postponed for market reasons.GRA
Q4 202420 Jan 2026 - Revenue up 16% and margin expansion achieved, with positive EBITDA and growth outlook.GRA
Q1 202515 Jan 2026 - Revenue up 14% and EBITDA positive as US expansion and graphene growth initiatives accelerate.GRA
Q2 202523 Dec 2025 - Adjusted EBITDA rose despite a 10% revenue drop; growth expected in 2026 from new programs.GRA
Q3 202525 Nov 2025 - Revenue fell 30% in Q1, but new contracts and financing set up a strong H2 recovery.GRA
Q1 202617 Nov 2025 - Full-year adjusted EBITDA more than doubled despite lower Q4 revenue and macro headwinds.GRA
Q4 202517 Sep 2025